Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) saw strong trading volume on Thursday . 2,001 shares were traded during trading, an increase of 271% from the previous session’s volume of 540 shares.The stock last traded at $13.53 and had previously closed at $13.57.
Ambu A/S Stock Down 1.8%
The company has a market cap of $3.18 billion, a PE ratio of 39.79 and a beta of 0.94. The stock has a 50-day moving average of $13.61 and a 200-day moving average of $14.59. The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 0.08.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its earnings results on Wednesday, November 5th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 10.00% and a return on equity of 10.35%.
Ambu A/S Company Profile
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Further Reading
- Five stocks we like better than Ambu A/S
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
